Intended for healthcare professionals

News

Esketamine is approved in Europe for treating resistant major depressive disorder

BMJ 2019; 367 doi: https://doi.org/10.1136/bmj.l7069 (Published 20 December 2019) Cite this as: BMJ 2019;367:l7069

Article usage

Article metrics provide readers and authors with an indication of how often a specific article has been accessed month by month. It counts three formats - abstract/extract, full text and pdf. The page is updated each day.

Usage statistics: December 2019 to December 2023

Rendering graph...
AbstractFullPdf
Dec 2019282032256
Jan 20201352514121
Feb 202060513450
Mar 20202984616
May 20202642328
Jun 20201893712
Jul 20202282916
Aug 20202103513
Sep 20202274211
Oct 20202293416
Nov 20201936616
Dec 2020220489
Jan 20212366015
Feb 2021313727
Mar 20213226221
Apr 20212573513
May 20211864015
Jun 2021187214
Jul 20211354812
Aug 2021135328
Sep 2021143466
Oct 2021164708
Nov 2021194365
Dec 2021158294
Jan 20222065813
Feb 2022127477
Mar 20222021716
Apr 20221741814
May 2022142284
Jun 2022133296
Jul 2022243487
Aug 2022107292
Sep 2022110365
Oct 2022124237
Nov 2022154407
Dec 2022121195
Jan 2023143313
Feb 2023152165
Mar 2023210226
Apr 2023145289
May 2023177173
Jun 2023584400
Jul 2023217392
Aug 202321895
Sep 2023234184
Oct 202311091
Nov 2023177325
Dec 20231331
Total134882537619